Copyright Reports & Markets. All rights reserved.

Global Small Molecule CXO Market Growth (Status and Outlook) 2021-2026

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Small Molecule CXO Market Size 2016-2026
    • 2.1.2 Small Molecule CXO Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 Small Molecule CXO Segment by Type
    • 2.2.1 CRO
    • 2.2.2 CRO
    • 2.2.3 CDMO
    • 2.2.4 CMO
  • 2.3 Small Molecule CXO Market Size by Type
    • 2.3.1 Global Small Molecule CXO Market Size CAGR by Type
    • 2.3.2 Global Small Molecule CXO Market Size Market Share by Type (2016-2021)
  • 2.4 Small Molecule CXO Segment by Application
    • 2.4.1 Pharmaceutical
    • 2.4.2 Biopharmaceutical
  • 2.5 Small Molecule CXO Market Size by Application
    • 2.5.1 Global Small Molecule CXO Market Size CAGR by Application
    • 2.5.2 Global Small Molecule CXO Market Size Market Share by Application (2016-2021)

3 Small Molecule CXO Market Size by Players

  • 3.1 Small Molecule CXO Market Size Market Share by Players
    • 3.1.1 Global Small Molecule CXO Revenue by Players (2019-2021E)
    • 3.1.2 Global Small Molecule CXO Revenue Market Share by Players (2019-2021E)
  • 3.2 Global Small Molecule CXO Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Small Molecule CXO by Regions

  • 4.1 Small Molecule CXO Market Size by Regions (2016-2021)
  • 4.2 Americas Small Molecule CXO Market Size Growth (2016-2021)
  • 4.3 APAC Small Molecule CXO Market Size Growth (2016-2021)
  • 4.4 Europe Small Molecule CXO Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa Small Molecule CXO Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas Small Molecule CXO Market Size by Country (2016-2021)
  • 5.2 Americas Small Molecule CXO Market Size by Type (2016-2021)
  • 5.3 Americas Small Molecule CXO Market Size by Application (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Small Molecule CXO Market Size by Region (2016-2021)
  • 6.2 APAC Small Molecule CXO Market Size by Type (2016-2021)
  • 6.3 APAC Small Molecule CXO Market Size by Application (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Small Molecule CXO by Country (2016-2021)
  • 7.2 Europe Small Molecule CXO Market Size by Type (2016-2021)
  • 7.3 Europe Small Molecule CXO Market Size by Application (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Small Molecule CXO by Region (2016-2021)
  • 8.2 Middle East & Africa Small Molecule CXO Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa Small Molecule CXO Market Size by Application (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global Small Molecule CXO Market Forecast

  • 10.1 Global Small Molecule CXO Forecast by Regions (2021-2026)
    • 10.1.1 Global Small Molecule CXO Forecast by Regions (2021-2026)
    • 10.1.2 Americas Small Molecule CXO Forecast
    • 10.1.3 APAC Small Molecule CXO Forecast
    • 10.1.4 Europe Small Molecule CXO Forecast
    • 10.1.5 Middle East & Africa Small Molecule CXO Forecast
  • 10.2 Americas Small Molecule CXO Forecast by Countries (2021-2026)
    • 10.2.1 United States Small Molecule CXO Market Forecast
    • 10.2.2 Canada Small Molecule CXO Market Forecast
    • 10.2.3 Mexico Small Molecule CXO Market Forecast
    • 10.2.4 Brazil Small Molecule CXO Market Forecast
  • 10.3 APAC Small Molecule CXO Forecast by Region (2021-2026)
    • 10.3.1 China Small Molecule CXO Market Forecast
    • 10.3.2 Japan Small Molecule CXO Market Forecast
    • 10.3.3 Korea Small Molecule CXO Market Forecast
    • 10.3.4 Southeast Asia Small Molecule CXO Market Forecast
    • 10.3.5 India Small Molecule CXO Market Forecast
    • 10.3.6 Australia Small Molecule CXO Market Forecast
  • 10.4 Europe Small Molecule CXO Forecast by Country (2021-2026)
    • 10.4.1 Germany Small Molecule CXO Market Forecast
    • 10.4.2 France Small Molecule CXO Market Forecast
    • 10.4.3 UK Small Molecule CXO Market Forecast
    • 10.4.4 Italy Small Molecule CXO Market Forecast
    • 10.4.5 Russia Small Molecule CXO Market Forecast
  • 10.5 Middle East & Africa Small Molecule CXO Forecast by Region (2021-2026)
    • 10.5.1 Egypt Small Molecule CXO Market Forecast
    • 10.5.2 South Africa Small Molecule CXO Market Forecast
    • 10.5.3 Israel Small Molecule CXO Market Forecast
    • 10.5.4 Turkey Small Molecule CXO Market Forecast
    • 10.5.5 GCC Countries Small Molecule CXO Market Forecast
  • 10.6 Global Small Molecule CXO Forecast by Type (2021-2026)
  • 10.7 Global Small Molecule CXO Forecast by Application (2021-2026)

11 Key Players Analysis

  • 11.1 IQVIA
    • 11.1.1 IQVIA Company Information
    • 11.1.2 IQVIA Small Molecule CXO Product Offered
    • 11.1.3 IQVIA Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 IQVIA Main Business Overview
    • 11.1.5 IQVIA Latest Developments
  • 11.2 Labcorp
    • 11.2.1 Labcorp Company Information
    • 11.2.2 Labcorp Small Molecule CXO Product Offered
    • 11.2.3 Labcorp Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 Labcorp Main Business Overview
    • 11.2.5 Labcorp Latest Developments
  • 11.3 PPD
    • 11.3.1 PPD Company Information
    • 11.3.2 PPD Small Molecule CXO Product Offered
    • 11.3.3 PPD Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 PPD Main Business Overview
    • 11.3.5 PPD Latest Developments
  • 11.4 Wuxi Apptec
    • 11.4.1 Wuxi Apptec Company Information
    • 11.4.2 Wuxi Apptec Small Molecule CXO Product Offered
    • 11.4.3 Wuxi Apptec Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 Wuxi Apptec Main Business Overview
    • 11.4.5 Wuxi Apptec Latest Developments
  • 11.5 PharmaBlock
    • 11.5.1 PharmaBlock Company Information
    • 11.5.2 PharmaBlock Small Molecule CXO Product Offered
    • 11.5.3 PharmaBlock Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 PharmaBlock Main Business Overview
    • 11.5.5 PharmaBlock Latest Developments
  • 11.6 Asym Chemical
    • 11.6.1 Asym Chemical Company Information
    • 11.6.2 Asym Chemical Small Molecule CXO Product Offered
    • 11.6.3 Asym Chemical Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 Asym Chemical Main Business Overview
    • 11.6.5 Asym Chemical Latest Developments
  • 11.7 Jiuzhou Pharmaceutical
    • 11.7.1 Jiuzhou Pharmaceutical Company Information
    • 11.7.2 Jiuzhou Pharmaceutical Small Molecule CXO Product Offered
    • 11.7.3 Jiuzhou Pharmaceutical Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 Jiuzhou Pharmaceutical Main Business Overview
    • 11.7.5 Jiuzhou Pharmaceutical Latest Developments
  • 11.8 Pharmaron Beijing
    • 11.8.1 Pharmaron Beijing Company Information
    • 11.8.2 Pharmaron Beijing Small Molecule CXO Product Offered
    • 11.8.3 Pharmaron Beijing Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 Pharmaron Beijing Main Business Overview
    • 11.8.5 Pharmaron Beijing Latest Developments
  • 11.9 Porton Pharma
    • 11.9.1 Porton Pharma Company Information
    • 11.9.2 Porton Pharma Small Molecule CXO Product Offered
    • 11.9.3 Porton Pharma Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
    • 11.9.4 Porton Pharma Main Business Overview
    • 11.9.5 Porton Pharma Latest Developments
  • 11.10 ChemPartner
    • 11.10.1 ChemPartner Company Information
    • 11.10.2 ChemPartner Small Molecule CXO Product Offered
    • 11.10.3 ChemPartner Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
    • 11.10.4 ChemPartner Main Business Overview
    • 11.10.5 ChemPartner Latest Developments

11. Tigermed

  • 11.11.1 Tigermed Company Information
  • 11.11.2 Tigermed Small Molecule CXO Product Offered
  • 11.11.3 Tigermed Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
  • 11.11.4 Tigermed Main Business Overview
  • 11.11.5 Tigermed Latest Developments
  • 11.12 Shanghai Medicilon
    • 11.12.1 Shanghai Medicilon Company Information
    • 11.12.2 Shanghai Medicilon Small Molecule CXO Product Offered
    • 11.12.3 Shanghai Medicilon Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
    • 11.12.4 Shanghai Medicilon Main Business Overview
    • 11.12.5 Shanghai Medicilon Latest Developments
  • 11.13 VIVA Biotech Holdings
    • 11.13.1 VIVA Biotech Holdings Company Information
    • 11.13.2 VIVA Biotech Holdings Small Molecule CXO Product Offered
    • 11.13.3 VIVA Biotech Holdings Small Molecule CXO Revenue, Gross Margin and Market Share (2019-2021)
    • 11.13.4 VIVA Biotech Holdings Main Business Overview
    • 11.13.5 VIVA Biotech Holdings Latest Developments
  • 11.14 Chengdu Hitgen
    • 11.14.1 Chengdu Hitgen Company Information
    • 11.14.2 Chengdu Hitgen Small Molecule CXO Product Offered

    • According to this latest study, the 2021 growth of Small Molecule CXO will have significant change from previous year. By the most conservative estimates of global Small Molecule CXO market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Small Molecule CXO market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

    This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule CXO market by product type, application, key players and key regions and countries.

    Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
    CRO
    CMC
    CDMO
    CMO

    Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
    Pharmaceutical
    Biopharmaceutical

    This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    IQVIA
    Labcorp
    PPD
    Wuxi Apptec
    PharmaBlock
    Asym Chemical
    Jiuzhou Pharmaceutical
    Pharmaron Beijing
    Porton Pharma
    ChemPartner
    Tigermed
    Shanghai Medicilon
    VIVA Biotech Holdings
    Chengdu Hitgen
    Nanjing Genscript
    ICON plc
    PRA Health
    Syneos Health
    Buy now